Mark Evans
Europe, England, United Kingdom, London'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
Description
Mark is currently a Founding Partner and LP and Investment Committee member at Kindred Capital, a European Seed-Stage Venture fund, based in...
Investor Profile
Mark Evans has made 4 investments, with 0 in the past 12 months and 25% as lead.
Stage Focus
- Seed (50%)
- Angel (25%)
- Series A (25%)
Country Focus
- United Kingdom (75%)
- Germany (25%)
Industry Focus
- Biotechnology
- Life Science
- Health Care
- Artificial Intelligence (Ai)
- Biopharma
- Industrial Automation
- Pharmaceutical
- Robotics
- Apps
- Fitness
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.